Table 1.
References | Cohorts | Clinicopathologic data and detailed staging information | Analytical methods | Probes/primers/antibodies |
---|---|---|---|---|
Apaf-1 | ||||
Soengas et al.33 | 6 PMs | Unknown | gDNA: PCR | Microsatellite marker analysis on 12q22–23: D12S393 |
24 MMs | mRNA: ISH | Riboprobes targeting fragments: 1–461, 581–1363, 2112–2225, 3426–3710 | ||
mRNA: NB | cDNA fragments to nucleotides 272–2908 and 1517–3525 | |||
protein: IB | mAb 6–1–19, pAb 8.46 | |||
Fujimoto et al.34 | 62 PMs | PMs/MMs: Stage, thickness | gDNA: PCR | Microsatellite marker analysis on 12q22–23: D12S1657, D12S393, D12S1706, D12S346 |
112 MMs | mRNA: PCR | Forward 5’-ACATTTC TCACGATGCTACC-3’; reverse 5’-CAATTCATGAAGTGGCAA-3’ | ||
Fujimoto et al.35 | 49 MMs | Stage | gDNA: PCR | Microsatellite marker analysis on 12q22–23: D12S1657, D12S393, D12S1706, D12S346 |
Niedojadlo et al.36 | 75 nevi | PMs: Clark levels, thickness | mRNA: FISH | RNA probes prepared from a plasmid provided by Dr. Xang, University of Texas, USA |
53 PMs | protein: IHC | Rat mAb H19, provided by Dr. O'Reilly, WEHI, Melbourne, Australia | ||
24 MMs | ||||
Baldi et al.37 | 30 nevi | PMs: Thickness | protein: IHC | Rabbit pAb, H-324, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA |
61 PMs | ||||
15 MMs | ||||
Mustika et al.38 | 10 nevi | PMs: Thickness | protein: IHC | mAb, Santa Cruz Biotechnology Inc. |
11 in situ melanomas | ||||
26 PMs | ||||
15 MMs | ||||
Dai et al.39 | 13 nevi | PMs: Thickness | protein: IHC | Rabbit pAb, BD Biosciences, Mississauga, Ontario, Canada |
70 PMs | ||||
Zanon et al.40 | 8 nevi | Unknown | protein: FC | mAb from Chemicon International, Temecula, CA, USA |
16 PMs | protein: IHC | Rat mAb from Chemicon International | ||
71 MMs | ||||
Bachmann et al.41 | 31 nevi | PMs: Thickness | protein: IHC | pAb RB 9236, Neomarkers |
153 PMs | ||||
Caspases | ||||
Woenckhaus et al.49 | 16 nevi | PMs: Thickness | protein: IHC | Cleaved caspase-6, New England Biolabs, Frankfurt, Germany |
20 PMs | Cleaved caspase-3, New England Biolabs | |||
30 MMs | ||||
Chen et al.42 | 24 nevi | Cutaneous PMs: staging | protein: IHC | Caspase-3: rabbit pAb, Santa Cruz Biotechnology, Inc. |
52 PMs - cutaneous | Mucosal PMs: staging | Caspase-6: goat pAb, Santa Cruz Biotechnology, Inc. | ||
25 PMs - mucosal | Caspase-7: goat pAb, Santa Cruz Biotechnology, Inc. | |||
Liu et al.47 | 57 PMs | Thickness | protein: IHC | Rabbit anti-active caspase-3, Abcam, Cambridge, UK |
XIAP | ||||
Kluger et al.54 | 540 nevi | Unknown | protein: IHC | Mouse Ab, BD Transduction Laboratories |
232 PMs | ||||
299 MMs | ||||
Emanuel et al.53 | 6 nevi | PMs: Thickness | protein: IHC | Mouse mAb, clone 48, BD Biosciences, San Jose, CA, USA |
4 in situ melanomas | ||||
67 PMs | ||||
Chen et al.42 | 24 nevi | Cutaneous PMs: staging | protein: IHC | Rabbit pAb, Santa Cruz Biotechnology Inc. |
52 PMs - cutaneous | Mucosal PMs: staging | |||
25 PMs - mucosal | ||||
Hiscutt et al.55 | 6 nevi | Staging and thickness | protein: IHC | mAb, BD Biosciences, Oxford, UK |
7 in situ melanomas | ||||
42 PMs | ||||
ML-IAP | ||||
Nachmias et al.59 | 27 PMs | Unknown | protein: IB | Mouse mAb, clone 88C570, Imgenex |
Gong et al.57 | 14 nevi | Unknown | mRNA: ISH | antisense 5'-CAAAGACGATGGACACGGC-3'; sense 5'-GCCGTGTCCATCGTCTTTG-3' |
19 PMs (cut/muc) | mRNA: RT-PCR | upstream 5'-ATGGGCTCTGAGGAGTTGCGTC-3'; | ||
15 MMs | downstream 5'-CATAGCAGAAGAAGCACCTCACCTTG-3' | |||
protein: IHC | Rabbit pAb, R&D Systems, Minneapolis, MN, USA | |||
Takeuchi et al.58 | 63 MMs | Staging | mRNA: qRT-PCR | FRET probe: 5'-FAM-TGAGCTGCCCACACCCAGGAGAG-BHQ-1-3' |
Chen et al.42 | 24 nevi | Cutaneous PMs: staging | protein: IHC | Goat pAb, Santa Cruz Biotechnology Inc. |
52 PMs - cutaneous | Mucosal PMs: staging | |||
25 PMs - mucosal | ||||
Apollon | ||||
Tassi et al.61 | 8 PMs (cell lines) | Unknown | protein: FC, IB | Mouse Ab, BD Biosciences |
26 MMs (cell lines) | ||||
c-IAPs | ||||
Chen et al.42 | 24 nevi | Cutaneous PMs: staging | protein: IHC | c-IAP1: rabbit pAb, Santa Cruz Biotechnology Inc. |
52 PMs - cutaneous | Mucosal PMs: staging | c-IAP2: rabbit pAb, Santa Cruz Biotechnology Inc. | ||
25 PMs - mucosal | ||||
XAF1 | ||||
Ng et al.65 | 40 nevi | PMs: Thickness | protein: IHC | Rabbit Ab provided by Dr. Korneluk, University of Ottawa, Canada |
70 PMs |
Abbreviations: Cut, cutaneous; FC, flow cytometry; FISH, fluorescence in situ hybridization; IB, immunoblot; IHC, immunohistochemistry; ISH, in situ hybridization; MM, metastatic melanoma; muc, mucosal; NB, Northern blot; PCR, polymerase chain reaction; PM, primary melanoma; qRT-PCR, quantitative real time polymerase chain reaction.